Close Menu

NEW YORK – From its beginning as a diagnostic company with a focus on veterinary medicine, LexaGene has taken the path of many other firms since the pandemic began – transitioning technology and resources to detecting COVID-19 in humans. 

With its MiQLab sample-to-answer RT-PCR system, the firm is seeking to differentiate itself from competitors with a platform that facilitates the use of customizable syndromic panels that can look for 27 targets.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.